Summary
The association between the frequency of manifest infectious diseases and cancer risk was investigated in a case-control study at Heidelberg, FRG. A total of 255 cases with carcinomas of the stomach, colon, rectum, breast, and ovary, as well as 255 population controls and 230 hospital controls were interviewed using a standard questionnaire. Controls were matched to the cases for age, sex, and region of residence at the time of the interview. A history of common colds or gastroenteric influenza prior to the interview was found to be associated with a decreased cancer risk. Thus the odds ratios for “three or more common colds per year (on average)” versus “no common cold within the last 5 years prior to the interview” were 0.18 (95% CI=0.05–0.69) and 0.23 (95% CI=0.06–0.89) relative to population controls and hospital controls, respectively. There was no apparent relationship between childhood infections or other diseases reported in the earlier history, and cancer risk. While the findings are supported by previous studies and fit well into the results of other fields of cancer research, a conclusive interpretation and biological explanation cannot yet be given.
Similar content being viewed by others
References
Abel U (1987) Die antineoplastische Wirkung pyrogener Bakterientoxine. In: Hager ED, Abel U (eds) Biomodulation und Biotherapie des Krebses: II. Endogene Fiebertherapie und exogene Hyperthermie in der Onkologie. Verlag für Medizin Dr. E. Fischer, Heidelberg, pp21–85
Abel U (1990) Das Streptokokkenpräparat OK-432 in der Therapie maligner Tumoren. Preprint, Dept. Biostatistics, Deutsches Krebsforschungszentrum, Heidelberg
Braunstein A (1929) Krebs und Malaria. Z Krebsforsch 29:330–331
Breslow NE, Day NE (1980) Statistical methods in cancer research, vol 1. The analysis of case-control studies. IARC Sci Publ 32, Lyon
Chilvers C, Johnson B, Leach S et al. (1986) The common cold, allergy, and cancer. Br J Cancer 54:123–126
Cole WH (1976) Spontaneous regression of cancer and the importance of finding its cause. NCI Monogr 44:5–9
Engel P (1934) Über den Infektionsindex der Krebskranken. Wien Klin Wochenschr 47:1118–1119
Engel P (1935) Über den Einfluß des Alters auf den Infektionsindex der Krebskranken. Wien Klin Wochenschr 48:112
Enterline PhE, Sykora JL, Keleti G et al. (1985) Endotoxins, cotton dust, and cancer. Lancet 2:934–935
Fucini C, Bandettini L, D'Elia M et al. (1985) Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure? Dis Colon Rectum 28:94–95
Giese M, Kirchner H (1988) Interferone und ihre Wirkungen. Onkologie 11:151–154
Grossarth-Maticek R, Frentzel-Beyme R, Kanazir D et al. (1987) Reported Herpes-virus-infection, fever and cancer incidence in a prospective study. J Chronic Dis 40:967–976
Grufferman S, Wang HH, DeLong ER et al. (1982) Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst 68:107–113
Güttlich H (1960) Erkranken Tonsillektomierte seltener am Carcinom der oberen Luft- und Speisewege? HNO 9:47–49
Huth EF (1957) Die Rolle der bakteriellen Infektionen bei der Spontanremission maligner Tumoren und Leukosen. In: Lampert H, Selawry O (eds) Körpereigene Abwehr und bösartige Geschwülste. Haug-Verlag, Ulm, pp 23–37
Jentgens H, Matzker J, Steinhaus Chr (1978) Tonsillektomiefrequenz bei Bronchialkarzinomträgern. Laryngol Rhinol 57:190–193
Kessler I (1970) Lymphoid tissues in neoplasia. Cancer 25:510–522
Kofler E, Hussarek M (1954) Konstitutionelle Faktoren bei Rhinitis vasomotoria, Nasenpolypen und Carcinoma nasi. Krebsarzt 9:89–94
Matzker J, Klasen H-P (1975) Tonsillektomie und Leukämie im Kindesalter. Laryngol Rhinol 54:991–997
Matzker J, Schmidt P (1963) Zur Frage eines Zusammenhangs zwischen Gaumentonsillen und Karzinom der Luft- und Speisewege. Laryngol Rhinol 42:363–371
Matzker J, Steinberg A (1976) Tonsillektomie und Leukämie im Erwachsenenalter. Laryngol Rhinol 55:721–725
Müller W, Regazzoni P (1975) Verbessert ein lokaler postoperativer Infekt die Prognose beim Kolonkarzinom? Helv Chir Acta 42:205–208
Nauts HC (1980) The beneficial effects of bacterial infections in host resistance to cancer. End results in 449 cases. Monograph 8, Cancer Research Institute, New York
Nauts HC (1990) Bibliography of reports concerning the clinical or experimental use of Coley's toxins (Streptococcus pyogenes andSerratia marcescens) 1893–1990. Cancer Research Institute, New York
Nowacki MP, Szymendera JJ (1983) The strongest prognostic factors in colorectal carcinoma. Dis Colon Rectum: 263–268
Remy W, Hammerschmid K, Zänker KS et al. (1983) Tumorträger haben selten Infekte in der Anamnese. Med Klin 78:95–98
Ruckdeschel JC, Codish SD, Stranahan A et al. (1972) Postoperative empyema improves survival in lung cancer. N Engl J Med 287:1013–1017
Schmidt R (1910) Krebs und Infektionskrankheiten. Med Klin 43:1690–1693
Schulz G (1969) Verhütet Fieber Karzinome? Münch Med Wschr 111:1051–1052
Sinek F (1936) Versuch einer statistischen Erfassung endogener Faktoren bei Carcinomkranken. Z Krebsforsch 44:492–527
van Steensel-Moll HA, Valkenburg HA, van Zanen GE (1986) Childhood leukemia and infectious diseases in the first year of life: a register-based case-control study. Am J Epidemiol 124:590–594
Stephenson HE, Delmez JA, Renden DI et al. (1971) Host immunity and spontaneous regression of cancer evaluated by computerized data reduction study. Surg Gynecol Obstet 133:649–655
Takita H (1970) Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg 59:642–644
Ungar FH (1953) Problem of allergy and malignant tumours. Acta Unio Int Contra Cancrum 9:213–216
Witzel L (1970) Anamnese und Zweiterkrankungen bei Patienten mit bösartigen Neubildungen. Med Klin 65:876–879
Author information
Authors and Affiliations
Additional information
This work was supported by the Bundesministerium für Jugend, Familie, Frauen und Gesundheit
Rights and permissions
About this article
Cite this article
Abel, U., Becker, N., Angerer, R. et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 117, 339–344 (1991). https://doi.org/10.1007/BF01630717
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01630717